人类PLN-R14del心肌病症中细胞内膜网膜负荷变化
Willem Borbein1,2, Lukas Dahmlos1,2, Umber Saleem1,2
1Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Frontiers in cell and developmental biology
|August 12, 2025
概括
索兰班R14del变体通过改变内质网膜负荷导致心肌病. 这项研究确定了这种ER不平衡是PLN-R14del扩展性心肌病的新机制.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 索兰班 (PLN) R14del遗传变异是一种已知的扩张性心肌病的原因.
- 之前的研究表明,内质网膜 (ER) 应激反应和受损的ER信号通路,如自,都参与其中.
- 导致PLN-R14del心肌病的精确分子机制需要进一步阐明.
研究的目的:
- 研究ER平衡在PLN-R14del心肌病中的作用.
- 验证一种用于测量心肌细胞中ER负荷的新型传感器.
- 为了确定与PLN R14del变种相关的新疾病机制.
主要方法:
- 利用人类诱导的多能干细胞 (hiPSC) 衍生心肌细胞 (CMs) 来自对照,PLN-R14del患者和同源对照细胞系.
- 采用腺相关病毒血清型6 (AAV6) 来传递内分泌网膜传感器CEPIAer.
- 构建工程心脏组织 (EHT) 并进行光激活细胞分类 (FACS) 分析.
主要成果:
- CEPIAer光强度有效地作为所有细胞类型的ER负载的替代品.
- PLN-R14del心肌细胞在细胞质处理中表现出微妙的变化,与增加的ER负载相一致.
- FACS分析证实PLN-R14del患者心肌细胞的ER负荷较高.
结论:
- 改变ER负荷代表了PLN-R14del心肌病的新发现的疾病机制.
- 这一发现为管理PLN变体引起的扩张性心肌病症提供了潜在的新治疗标.
- 这项研究证实CEPIAer是评估心脏研究中ER动态的可靠工具.
相关概念视频
Cardiomyopathy IV: Restrictive Cardiomyopathy
31
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
31
Cardiomyopathy III: Hypertrophic Cardiomyopathy
48
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
48
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Cardiomyopathy I: Introduction and Classification
53
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
53


